(Q35172119)

6 August 2017

1 reference

title

Primary biliary cirrhosis and hepatocellular carcinoma (English)

1 reference

primary biliary cholangitis

6 August 2017

0 references

0 references

M Eric Gershwin

1 reference

6 August 2017

Jorge Findor

1 reference

6 August 2017

Xiao-Song He

series ordinal

1 reference

6 August 2017

Juan Sord

series ordinal

1 reference

6 August 2017

Ruben Terg

series ordinal

1 reference

6 August 2017

language of work or name

1 reference

1 August 2002

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

220-225

1 reference

Primary biliary cirrhosis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Aetiological factors in hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Epidemiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Hepatitis C virus and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Increase in primary liver cancer in the UK, 1979–94

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: Evidence from Southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Pathogenesis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Activation of p53 tumor suppressor by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

The variable course of primary hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Hepatocellular carcinoma in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Hepatic and extrahepatic malignancies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Hepatocellular carcinoma in primary biliary cirrhosis: an autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

Primary biliary cirrhosis: an orchestrated immune response against epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900050-2

7 January 2021

10.1016/S1568-9972(02)00050-2

Identifiers

DOI

1 reference

6 August 2017

1 reference